It’s Time to Ban Atrazine

Enlarge Image Image Gallery Recently determined to be a suspected carcinogen, atrazine herbicide is a pervasive contaminant in U.S. drinking water. PHOTO: AGSTOCK/MITCH KEZAR

The herbicide atrazine is in the news for multiple reasons these days, as Tom Philpott explains below. In addition to concerns that this widely used pesticide may cause cancer, evidence has recently surfaced showing that, for more than a decade, Syngenta has spent millions of dollars to pay scientists and journalists to deny and deflect the growing documentation of the human health dangers posed by atrazine. Plus, cancer is not the only concern with this chemical; a new report from the National Institute of Environmental Health Sciences names atrazine among a group of endocrine-disrupting chemicals that are “obesogens” — meaning they are suspected of contributing to the obesity epidemic now underway in this country. Here are links to these important stories:  

Developing News and Information About Atrazine

• Syngenta Spends Millions to Deflect Evidence Against Atrazine Herbicide 
• Obesogens: An Environmental Link to Obesity 

Ban Atrazine NOW!

Atrazine is the second most widely used pesticide in the United States. Farmers have been using it since its registration in 1958 to control weeds in fields of corn, grain sorghum and other crops, and it has pervasively contaminated our drinking water for years.

The Environmental Protection Agency (EPA), which regulates pesticide use, has been operating under the assumption that atrazine (produced by Syngenta) is “not likely to be a human carcinogen.” But in 2009, the agency launched what it called a “comprehensive new evaluation of atrazine to determine its effects on humans.” As part of the process, it charged a panel made up of independent scientists and public health experts to “evaluate the pesticide’s potential cancer and non-cancer effects.”

In late 2011, the EPA released the minutes of the expert panel’s final meeting. Its conclusions were stark. The panel criticized the EPA for lumping all forms of cancer together in its atrazine assessment. It then gave a list of cancers for which there is “suggestive evidence of carcinogenic potential”: ovarian cancer, non-Hodgkin’s lymphoma, hairy-cell leukemia and thyroid cancer. For other cancers — prostate, breast, liver, and esophageal and childhood cancers — the panel found that “there is inadequate evidence” to determine whether or not atrazine is a cause.